3M makes roughly 60,000 different products across three business segments: Safety and Industrial, Transportation and Electronics, and Consumer. Its biggest names are things most people have used: Post-it notes, Scotch tape, Command hooks, Filtrete air filters, Nexcare bandages, and Scotch-Brite sponges. The company sells these through retailers, wholesalers, and e-commerce channels in markets all around the world. Most of what 3M sells are consumables, meaning customers use them up and come back for more, which is supposed to create a steady, repeating stream of revenue. The diagram below traces where the money goes.
Five years of financial data tell a story of a company that shrank sharply and then levelled off. Revenue was $35.4 billion in 2021 and dropped to $26.2 billion in 2022, a fall of more than $9 billion in a single year. It kept declining to $24.6 billion in 2023, where it stayed flat in 2024, before a modest recovery to $24.9 billion in 2025. A big part of the shrinkage was structural: 3M spun off its Health Care business as a separate company called Solventum in April 2024, removing an entire segment from its reported numbers.
Gross margin, the share of each sales dollar left after making the goods, tells its own story. It was 46.8 percent in 2021, fell to 39.4 percent in 2022, and has stayed in the 39 to 41 percent range since then. The 2021 figure looks high partly because the Health Care business, which carried better margins, was still inside 3M. The company that remains is leaner but also structurally less profitable per dollar of sales than the old 3M.
Cash generation is where the numbers get harder to read. Operating cash flow dropped from $7.5 billion in 2021 to just $1.8 billion in 2024, and free cash flow, the money left after capital spending, fell from $5.9 billion in 2021 to only $0.6 billion in 2024. Both numbers recovered slightly in 2025, with operating cash of $2.3 billion and free cash flow of $1.4 billion. The main culprit is not the core business falling apart but rather the enormous legal settlements 3M has been paying out.
3M has agreed to pay between $10.5 billion and $12.5 billion to settle lawsuits from public water systems in the United States over PFAS contamination. Separately, the company agreed to pay $6 billion between 2023 and 2029 to settle claims from military veterans who say Combat Arms earplugs damaged their hearing. These two legal obligations together represent a massive ongoing drain on cash, and they are the main reason free cash flow looks so different today compared to 2021.
On the positive side, net debt has been falling, from $17.4 billion in 2021 to $12.6 billion in 2025. The company also completed its exit from PFAS manufacturing at the end of 2025, which removes one ongoing source of cost and liability. The Safety and Industrial segment, which makes up 45.6 percent of total sales, grew organically by 3.2 percent in 2025 and expanded its operating margin to 24.9 percent. The Consumer segment, at 19.7 percent of sales, held roughly flat in revenue while improving its operating margin to 20.2 percent.
Transportation and Electronics, which makes up 33.2 percent of sales, is the weakest link right now. Total sales fell 1.3 percent in 2025. Part of that was the deliberate wind-down of PFAS-manufactured products inside that segment. Adjusted to remove that effect, the segment grew 2.3 percent. But the underlying operating margin still fell year over year, squeezed by lower automotive production volumes, headwinds in advanced materials, and cost dis-synergies from exiting PFAS manufacturing.
3M operates in a mature market where most homes and factories already use its products. That means growth has to come from winning more share, launching new products, or raising prices, not from a wave of new customers discovering what Scotch tape is. More than half of 3M's revenue comes from outside the United States, which means currency movements can swing the reported numbers even when the underlying business is holding steady.
The documented risk factors are specific and serious. PFAS lawsuits are the biggest. Even though 3M has settled the public water systems case, it faces many other ongoing government investigations and lawsuits about PFAS, and stricter future regulations could create additional costs beyond what is already accrued. The Combat Arms earplug settlement of $6 billion runs through 2029, but there is a risk of further claims or legal challenges to the settlement itself. A single-source supplier problem is another real threat: 3M depends on suppliers who are sometimes the only source for certain materials, and a disruption at one of those suppliers could halt production of affected products. Finally, 3M is in the middle of installing a new company-wide computer system over several years. Cybersecurity breaches or delays in that system could disrupt operations in ways the company says it cannot fully insure against.